Trademark: RESOLIAN BIOANALYTICS 2355826
Word
RESOLIAN BIOANALYTICS
ID
2355826
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
31 March 2023
Registration Date
31 March 2023
Renewal Date
31 March 2033
Owner(s)
Service
Goods and Services:
Class 42:
Laboratory testing services in clinical research and clinical trials of innovator and generic medicines in the pharmaceutical and biotechnology fields; research and development in the fields of bioanalysis, immunoassay development, validation and testing, biomarker studies, drug metabolism, and pharmacokinetic testing; pharmaceutical research and development services; chemical, bioanalytical, biological and biotechnology research services; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; pharmaceutical drug development services; scientific testing for medical and pharmaceutical research purposes; drug and chemical materials analysis services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmaceutical, biopharmaceutical, biotechnology and medical device development; operating and maintaining a biorepository for medical and scientific research purposes; laboratory services; Good Manufacturing Practices (GMP) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; analytical services, namely, providing Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of therapeutic drug evaluation and development.
Laboratory testing services in clinical research and clinical trials of innovator and generic medicines in the pharmaceutical and biotechnology fields; research and development in the fields of bioanalysis, immunoassay development, validation and testing, biomarker studies, drug metabolism, and pharmacokinetic testing; pharmaceutical research and development services; chemical, bioanalytical, biological and biotechnology research services; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; pharmaceutical drug development services; scientific testing for medical and pharmaceutical research purposes; drug and chemical materials analysis services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmaceutical, biopharmaceutical, biotechnology and medical device development; operating and maintaining a biorepository for medical and scientific research purposes; laboratory services; Good Manufacturing Practices (GMP) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; analytical services, namely, providing Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of therapeutic drug evaluation and development.